Cargando…
Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
PURPOSE: The role of streptozocin-based chemotherapy (STZ CTx) in advanced, well-differentiated pancreatic neuroendocrine tumours (PanNET) and the best sequence of treatments in advanced PanNET are unclear. We examined the outcomes after STZ CTx in patients who had been selected according to the cur...
Autores principales: | Lahner, Harald, Mathew, Annie, Klocker, Anna Lisa, Unger, Nicole, Theysohn, Jens, Rekowski, Jan, Jöckel, Karl-Heinz, Theurer, Sarah, Schmid, Kurt Werner, Herrmann, Ken, Führer, Dagmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763729/ https://www.ncbi.nlm.nih.gov/pubmed/34480724 http://dx.doi.org/10.1007/s12020-021-02859-y |
Ejemplares similares
-
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
por: Turner, N C, et al.
Publicado: (2010) -
Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
por: Gonzalez, M A, et al.
Publicado: (2003) -
Long-term treatment with streptozocin/5-fluorouracil chemotherapy in patients with metastatic pancreatic neuroendocrine tumors: Case series
por: Müller, Christian, et al.
Publicado: (2022) -
A Case of Streptozocin Monotherapy for Unresectable Duodenal Neuroendocrine Tumor G2
por: Miyagawa, Koji, et al.
Publicado: (2019) -
Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma – Lessons From Individual Cases With Long-Term Follow-Up
por: Brandenburg, Tim, et al.
Publicado: (2021)